Wealth Enhancement Advisory Services’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$405K Buy
22,767
+678
+3% +$15.5K ﹤0.01% 2898
2026
Q1
$476K Buy
22,089
+1,398
+7% +$24.3K ﹤0.01% 2358
2025
Q4
$275K Buy
20,691
+7,511
+57% +$96.4K ﹤0.01% 2996
2025
Q3
$199K Buy
13,180
+186
+1% +$2.7K ﹤0.01% 3145
2025
Q2
$168K Buy
12,994
+2,039
+19% +$23K ﹤0.01% 3034
2025
Q1
$148K Sell
10,955
-147
-1% -$2.44K ﹤0.01% 2688
2024
Q4
$188K Buy
11,102
+99
+0.9% +$1.93K ﹤0.01% 2704
2024
Q3
$224K Buy
11,003
+290
+3% +$5.93K ﹤0.01% 2382
2024
Q2
$242K Sell
10,713
-1,400
-12% -$36.7K ﹤0.01% 2145
2024
Q1
$318K Buy
12,113
+3,302
+37% +$94.1K ﹤0.01% 1881
2023
Q4
$278K Buy
8,811
+435
+5% +$11.8K ﹤0.01% 1868
2023
Q3
$235K Buy
+8,376
New +$288K ﹤0.01% 1897

Other funds holding CC

Wealth Enhancement Advisory Services's CC Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Chemours (CC) stake by 3.1% in Q2 2026, buying an estimated $15.5K and bringing the position to 22,767 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #2898.

Wealth Enhancement Advisory Services first reported a position in CC in Q3 2023 and has held it in 12 quarters since. The position peaked at $476K in Q1 2026. 85 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Wealth Enhancement Advisory Services held 22,767 shares of Chemours worth $405K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 678 Chemours shares in Q2 2026, an estimated $15.5K.
  • Chemours made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2898 holding.
  • Wealth Enhancement Advisory Services first reported a position in Chemours in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Chemours position peaked at $476K in Q1 2026.
  • 85 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.